Literature DB >> 2914295

Porokeratosis as a premalignant condition of the skin. Cytologic demonstration of abnormal DNA ploidy in cells of the epidermis.

F Otsuka1, A Shima, Y Ishibashi.   

Abstract

Clinical evidence has accumulated of malignant epithelial tumors developing on the lesions of porokeratosis. To determine the cytologic basis for the malignant change of porokeratosis, the nuclear DNA content of epidermal cells from porokeratotic lesions was measured using microfluorometry. A total of 42% of 33 porokeratotic skin lesions in eight of the 16 patients showed DNA polyploidization in the epidermis. Most of the porokeratotic skin lesions, with or without DNA polyploidization, increase cell proportions in the S and G2/M phase range. DNA indices of cells from these porokeratotic lesions distributed widely from the level of normal control epidermis to that of malignant epidermal conditions. These findings suggest that porokeratosis is undergoing the neoplastic process, and is a precursor of malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914295     DOI: 10.1002/1097-0142(19890301)63:5<891::aid-cncr2820630516>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Porokeratosis and malignant skin tumors.

Authors:  F Otsuka; T Someya; Y Ishibashi
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Porokeratosis large skin lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility.

Authors:  F Otsuka; Y Umebayashi; S Watanabe; M Kawashima; S Hamanaka
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former.

Authors:  H I Chi; Y Uyeda; Y Umebayashi; F Otsuka
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

4.  Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method.

Authors:  Y Umebayashi; F Otsuka
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  DNA index and S phase fraction in uveal malignant melanomas.

Authors:  W G Hodge; A J Duclos; G Rocha; E Antecka; M G Baines; C Corriveau; S Brownstein; J Deschenes
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

6.  Clinical analysis and etiology of porokeratosis.

Authors:  Chao-Ying Gu; Cheng-Feng Zhang; Lian-Jun Chen; Lei-Hong Xiang; Zhi-Zhong Zheng
Journal:  Exp Ther Med       Date:  2014-06-24       Impact factor: 2.447

7.  Plaque-type verrucous porokeratosis of the back.

Authors:  Giovanni Paolino; Santo Raffaele Mercuri; Boulos Mansour; Matteo Riccardo Di Nicola; Manuela Carrera; Silvia Taccogna; Vittoria Giulia Bianchi; Pietro Donati; Michele Donati
Journal:  JAAD Case Rep       Date:  2022-09-05

Review 8.  Genitogluteal porokeratosis: a clinical review.

Authors:  Rajiv Joshi; Khushboo Minni
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.